The AstraZeneca jab was developed by scientists at the University of Oxford and the British-Swedish AstraZeneca.
Two versions of the jab have been approved for emergency use by the World Health Organization (WHO), one of which is produced by the Serum Institute of India and the other by AstraZeneca-SKBio in South Korea.
After an initial assessment, the EMA approved the vaccine for people aged 18 and above.
The WHO said: “People with a history of severe allergic reaction to any component of the vaccine should not take it.
“The vaccine is not recommended for persons younger than 18 years of age pending the results of further studies.”